Section Arrow
ASRT.NASDAQ
- Assertio Holdings
(Financial Status)
Quotes are at least 15-min delayed:2025/07/04 10:14 EDT
Last
 0.653
-0.0218 (-3.23%)
Day High 
0.6795 
Prev. Close
0.6748 
1-M High
0.6798 
Volume 
125.87K 
Bid
0.6615
Ask
0.6899
Day Low
0.64751 
Open
0.6567 
1-M Low
0.603 
Market Cap 
64.63M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.64 
20-SMA 0.65 
50-SMA 0.65 
52-W High 1.798 
52-W Low 0.5137 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.32/0.15
Enterprise Value
104.40M
Balance Sheet
Book Value Per Share
1.13
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
124.96M
Operating Revenue Per Share
1.75
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed:2025/07/04 10:14 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild tomoderate pain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.